Formulation and Drug Delivery

Considerations in Developing Sublingual Tablets—An Overview

November 02, 2014

This review highlights relevant physicochemical drug properties and formulation design considerations critical to quality and performance of the sublingual tablets.

PTSM: Pharmaceutical Technology Sourcing and Management

WHO Promotes International Collaboration for Generic Drug Approvals

November 01, 2014

The European Union takes the lead in a global pilot project on the marketing approval of generic medicines, highlighting the challenges of achieving consensus among different nations.

First Biosimilar Application Kicks Off Legal Battle

October 31, 2014

Amgen is suing Sandoz over Sandoz's biosimilar application for filgrastim.

SAFC Introduces New Protein Quality Supplement for Optimized Biologics Production

October 30, 2014

Sigma-Aldrich's custom manufacturing services business unit, SAFC, has launched a new protein quality supplement for biological drug production, including biosimilars.

Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment

October 29, 2014

Bristol-Myers Squibb announced that they have reached an agreement with F-star Alpha, giving BMS the exclusive option to acquire F-star's HER2-targeted breast and gastric cancer treatment.

Novartis Sells Influenza Vaccine Business to CSL for $275 Million

October 27, 2014

The divestment will create the number two player in the global influenza vaccine industry.

GSK Accelerates Ebola Vaccine Development

October 24, 2014

GSK's investigational Ebola vaccine is in Phase I safety trials.

J&J Speeds Ebola Vaccine Development and Expands Production

October 24, 2014

Johnson& Johnson is collaborating with WHO and others on clinical testing, development, production, and distribution of an Ebola vaccine.

EMA Works to Speed Up Ebola Treatment

October 20, 2014

The agency recommends that companies developing drugs to treat Ebola apply for orphan drug designation.

Evaluating Cross-Contamination Risk of Highly Potent APIs

October 15, 2014

Equipment and Processing Report

Manufacturers using highly potent APIs must examine cross-contamination routes and determine acceptable limits.